| Year |
Citation |
Score |
| 2023 |
Ranoa DRE, Sharma P, Schane CP, Lewis AN, Valdez E, Marada VVVR, Hager MV, Montgomery W, Wolf SP, Schreiber K, Schreiber H, Bailey K, Fan TM, Hergenrother PJ, Roy EJ, et al. Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse model. Journal For Immunotherapy of Cancer. 11. PMID 37258040 DOI: 10.1136/jitc-2022-006509 |
0.578 |
|
| 2021 |
Boudreau MW, Duraki D, Wang L, Mao C, Kim JE, Henn MA, Tang B, Fanning SW, Kiefer J, Tarasow TM, Bruckheimer EM, Moreno R, Mousses S, Greene GL, Roy EJ, ... ... Fan TM, et al. A small-molecule activator of the unfolded protein response eradicates human breast tumors in mice. Science Translational Medicine. 13. PMID 34290053 DOI: 10.1126/scitranslmed.abf1383 |
0.611 |
|
| 2020 |
Saba CF, Clifford CA, Burgess KE, Phillips BS, Vail DM, Wright ZM, Curran KM, Fan TM, Elmslie RS, Post GS, Thamm DH. Rabacfosadine For Naïve Canine Intermediate To Large Cell Lymphoma: Efficacy And Adverse Event Profile Across Three Prospective Clinical Trials. Veterinary and Comparative Oncology. PMID 32346934 DOI: 10.1111/Vco.12605 |
0.339 |
|
| 2020 |
Fan TM, Roberts RD, Lizardo MM. Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression. Frontiers in Oncology. 10: 13. PMID 32082995 DOI: 10.3389/Fonc.2020.00013 |
0.38 |
|
| 2020 |
Duraki D, Boudreau MW, Wang L, Mao C, Tang B, Ma L, Roy EJ, Fan TM, Park BH, Nelson ER, Hergenrother PJ, Shapiro DJ. OR05-05 Lethal ERα-Dependent Hyperactivation of the Unfolded Protein Response Induces Complete Regression Without Recurrence of Primary and Metastatic Breast Cancer Journal of the Endocrine Society. 4. DOI: 10.1210/Jendso/Bvaa046.653 |
0.641 |
|
| 2019 |
Roberts RD, Lizardo MM, Reed DR, Hingorani P, Glover J, Allen-Rhoades W, Fan T, Khanna C, Sweet-Cordero EA, Cash T, Bishop MW, Hegde M, Sertil AR, Koelsche C, Mirabello L, et al. Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group. Cancer. PMID 31355930 DOI: 10.1002/Cncr.32351 |
0.308 |
|
| 2019 |
Schlein LJ, Fadl-Alla B, Pondenis HC, Lezmi S, Eberhart CG, LeBlanc AK, Dickinson PJ, Hergenrother PJ, Fan TM. Immunohistochemical Characterization of Procaspase-3 Overexpression as a Druggable Target With PAC-1, a Procaspase-3 Activator, in Canine and Human Brain Cancers. Frontiers in Oncology. 9: 96. PMID 30859090 DOI: 10.3389/Fonc.2019.00096 |
0.348 |
|
| 2019 |
Dowling M, Samuelson J, Fadl-Alla B, Pondenis HC, Byrum M, Barger AM, Fan TM. Overexpression of prostate specific membrane antigen by canine hemangiosarcoma cells provides opportunity for the molecular detection of disease burdens within hemorrhagic body cavity effusions. Plos One. 14: e0210297. PMID 30601866 DOI: 10.1371/Journal.Pone.0210297 |
0.352 |
|
| 2018 |
Fan TM, Selting KA. Exploring the Potential Utility of Pet Dogs With Cancer for Studying Radiation-Induced Immunogenic Cell Death Strategies. Frontiers in Oncology. 8: 680. PMID 30697532 DOI: 10.3389/Fonc.2018.00680 |
0.372 |
|
| 2018 |
Roy J, Dibaeinia P, Fan TM, Sinha S, Das A. Global Analysis of Osteosarcoma Lipidomes Reveal Altered Lipid Profiles in Metastatic vs. Non-Metastatic Cells. Journal of Lipid Research. PMID 30504231 DOI: 10.1194/Jlr.M088559 |
0.505 |
|
| 2018 |
Overgaard NH, Fan TM, Schachtschneider KM, Principe DR, Schook LB, Jungersen G. Of Mice, Dogs, Pigs, and Men: Choosing the Appropriate Model for Immuno-Oncology Research. Ilar Journal. PMID 30476148 DOI: 10.1093/Ilar/Ily014 |
0.374 |
|
| 2018 |
Svec RL, Furiassi L, Skibinski CG, Fan TM, Riggins GJ, Hergenrother PJ. Tunable Stability of Imidazotetrazines Leads to a Potent Compound for Glioblastoma. Acs Chemical Biology. PMID 30296373 DOI: 10.1021/Acschembio.8B00864 |
0.315 |
|
| 2018 |
Anorma C, Hedhli J, Bearrood TE, Pino NW, Gardner SH, Inaba H, Zhang P, Li Y, Feng D, Dibrell SE, Kilian KA, Dobrucki LW, Fan TM, Chan J. Surveillance of Cancer Stem Cell Plasticity Using an Isoform-Selective Fluorescent Probe for Aldehyde Dehydrogenase 1A1. Acs Central Science. 4: 1045-1055. PMID 30159402 DOI: 10.1021/Acscentsci.8B00313 |
0.305 |
|
| 2018 |
Roy J, Watson JE, Hong I, Fan TM, Das A. Anti-Tumorigenic Properties of Omega-3 Endocannabinoid Epoxides. Journal of Medicinal Chemistry. PMID 29856219 DOI: 10.1021/Acs.Jmedchem.8B00243 |
0.465 |
|
| 2018 |
Yin Q, Tang L, Cai K, Yang X, Yin L, Zhang Y, Dobrucki LW, Helferich WG, Fan TM, Cheng J. Albumin as a "Trojan Horse" for polymeric nanoconjugate transendothelial transport across tumor vasculatures for improved cancer targeting. Biomaterials Science. PMID 29570190 DOI: 10.1039/C8Bm00149A |
0.371 |
|
| 2017 |
Joshi AD, Botham RC, Schlein LJ, Roth HS, Mangraviti A, Borodovsky A, Tyler B, Joslyn S, Looper JS, Podell M, Fan TM, Hergenrother PJ, Riggins GJ. Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patients. Oncotarget. 8: 80124-80138. PMID 29113289 DOI: 10.18632/Oncotarget.19085 |
0.322 |
|
| 2017 |
Lee J, Abdeen AA, Hedhli J, Wycislo KL, Dobrucka IT, Fan TM, Dobrucki LW, Kilian KA. Melanoma topology reveals a stem-like phenotype that promotes angiogenesis. Science Advances. 3: e1701350. PMID 29075670 DOI: 10.1126/Sciadv.1701350 |
0.335 |
|
| 2017 |
Roy J, Wycislo KL, Pondenis H, Fan TM, Das A. Comparative proteomic investigation of metastatic and non-metastatic osteosarcoma cells of human and canine origin. Plos One. 12: e0183930. PMID 28910304 DOI: 10.1371/Journal.Pone.0183930 |
0.501 |
|
| 2017 |
Saba CF, Vickery KR, Clifford CA, Burgess KE, Phillips B, Vail DM, Wright ZM, Morges MA, Fan TM, Thamm DH. Rabacfosadine for relapsed canine B-cell lymphoma: Efficacy and adverse event profiles of 2 different doses. Veterinary and Comparative Oncology. PMID 28891260 DOI: 10.1111/Vco.12337 |
0.306 |
|
| 2017 |
Zhang D, Lee J, Sun MB, Pei Y, Chu J, Gillette MU, Fan TM, Kilian KA. Combinatorial Discovery of Defined Substrates That Promote a Stem Cell State in Malignant Melanoma. Acs Central Science. 3: 381-393. PMID 28573199 DOI: 10.1021/Acscentsci.6B00329 |
0.373 |
|
| 2017 |
Thamm DH, Vail DM, Post GS, Fan TM, Phillips BS, Axiak-Bechtel S, Elmslie RS, Klein MK, Ruslander DA. Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric Lymphoma. Journal of Veterinary Internal Medicine. PMID 28370378 DOI: 10.1111/Jvim.14700 |
0.301 |
|
| 2017 |
Wang H, Wang R, Cai K, He H, Liu Y, Yen J, Wang Z, Xu M, Sun Y, Zhou X, Yin Q, Tang L, Dobrucki IT, Dobrucki LW, Chaney EJ, ... ... Fan TM, et al. Selective in vivo metabolic cell-labeling-mediated cancer targeting. Nature Chemical Biology. PMID 28192414 DOI: 10.1038/Nchembio.2297 |
0.354 |
|
| 2016 |
Lundberg AP, Francis JM, Pajak M, Parkinson EI, Wycislo KL, Rosol TJ, Brown ME, London CA, Dirikolu L, Hergenrother PJ, Fan TM. Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species. Investigational New Drugs. PMID 27975234 DOI: 10.1007/S10637-016-0414-Z |
0.37 |
|
| 2016 |
Botham RC, Roth HS, Book AP, Roady PJ, Fan TM, Hergenrother PJ. Small-Molecule Procaspase-3 Activation Sensitizes Cancer to Treatment with Diverse Chemotherapeutics. Acs Central Science. 2: 545-59. PMID 27610416 DOI: 10.1021/Acscentsci.6B00165 |
0.411 |
|
| 2016 |
Yin Q, Tang L, Cai K, Tong R, Sternberg R, Yang X, Dobrucki LW, Borst LB, Kamstock D, Song Z, Helferich WG, Cheng J, Fan TM. Pamidronate functionalized nanoconjugates for targeted therapy of focal skeletal malignant osteolysis. Proceedings of the National Academy of Sciences of the United States of America. PMID 27457945 DOI: 10.1073/Pnas.1603316113 |
0.35 |
|
| 2016 |
Morrow JJ, Mendoza A, Koyen A, Lizardo M, Ren L, Waybright TJ, Hansen RJ, Gustafson DL, Zhou M, Fan TM, Scacheri P, Khanna C. mTOR inhibition mitigates enhanced mRNA translation associated with the metastatic phenotype of osteosarcoma cells in vivo. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27342399 DOI: 10.1158/1078-0432.Ccr-16-0326 |
0.335 |
|
| 2016 |
Peh J, Fan TM, Wycislo KL, Roth HS, Hergenrother PJ. The combination of vemurafenib and procaspase-3 activation is synergistic in mutant BRAF melanomas. Molecular Cancer Therapeutics. PMID 27297867 DOI: 10.1158/1535-7163.Mct-16-0025 |
0.349 |
|
| 2016 |
Byrum ML, Pondenis HC, Fredrickson RL, Wycislo KL, Fan TM. Downregulation of CXCR4 Expression and Functionality After Zoledronate Exposure in Canine Osteosarcoma. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. PMID 27251585 DOI: 10.1111/Jvim.14257 |
0.302 |
|
| 2016 |
LeBlanc AK, Mazcko C, Brown DE, Koehler JW, Miller AD, Miller CR, Bentley RT, Packer RA, Breen M, Boudreau CE, Levine JM, Simpson RM, Halsey C, Kisseberth W, Rossmeisl JH, ... ... Fan TM, et al. Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients. Neuro-Oncology. PMID 27179361 DOI: 10.1093/Neuonc/Now051 |
0.321 |
|
| 2016 |
Lee J, Abdeen AA, Wycislo KL, Fan TM, Kilian KA. Interfacial geometry dictates cancer cell tumorigenicity. Nature Materials. PMID 27043781 DOI: 10.1038/Nmat4610 |
0.348 |
|
| 2015 |
Fan TM, Khanna C. Comparative Aspects of Osteosarcoma Pathogenesis in Humans and Dogs. Veterinary Sciences. 2: 210-230. PMID 29061942 DOI: 10.3390/Vetsci2030210 |
0.303 |
|
| 2015 |
Chakkath T, Lavergne S, Fan TM, Bunick D, Dirikolu L. Alkylation and Carbamylation Effects of Lomustine and Its Major Metabolites and MGMT Expression in Canine Cells. Veterinary Sciences. 2: 52-68. PMID 29061931 DOI: 10.3390/Vetsci2020052 |
0.315 |
|
| 2015 |
Neumann ZL, Pondenis HC, Masyr A, Byrum ML, Wycislo KL, Fan TM. The Association of Endothelin-1 Signaling with Bone Alkaline Phosphatase Expression and Protumorigenic Activities in Canine Osteosarcoma. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. PMID 26426813 DOI: 10.1111/Jvim.13635 |
0.314 |
|
| 2015 |
Roy J, Pondenis H, Fan TM, Das A. Direct Capture of Functional Proteins from Mammalian Plasma Membranes into Nanodiscs. Biochemistry. PMID 26415091 DOI: 10.1021/Acs.Biochem.5B00954 |
0.442 |
|
| 2015 |
Tang L, Tong R, Coyle VJ, Yin Q, Pondenis H, Borst LB, Cheng J, Fan TM. Targeting tumor vasculature with aptamer-functionalized doxorubicin-polylactide nanoconjugates for enhanced cancer therapy. Acs Nano. 9: 5072-81. PMID 25938427 DOI: 10.1021/Acsnano.5B00166 |
0.366 |
|
| 2015 |
Wycislo KL, Fan TM. The immunotherapy of canine osteosarcoma: a historical and systematic review. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 29: 759-69. PMID 25929293 DOI: 10.1111/Jvim.12603 |
0.364 |
|
| 2015 |
Roth HS, Botham RC, Schmid SC, Fan TM, Dirikolu L, Hergenrother PJ. Removal of Metabolic Liabilities Enables Development of Derivatives of Procaspase-Activating Compound 1 (PAC-1) with Improved Pharmacokinetics. Journal of Medicinal Chemistry. 58: 4046-65. PMID 25856364 DOI: 10.1021/Acs.Jmedchem.5B00413 |
0.321 |
|
| 2015 |
Joshi AD, Botham RC, Roth HS, Fan TM, Tarasow TM, Hergenrother PJ, Riggins GJ. Abstract 3620: An oral procaspase activating drug, PAC-1, shows preclinical promise for glioblastoma therapy Cancer Research. 75: 3620-3620. DOI: 10.1158/1538-7445.Am2015-3620 |
0.402 |
|
| 2014 |
Tang L, Yang X, Yin Q, Cai K, Wang H, Chaudhury I, Yao C, Zhou Q, Kwon M, Hartman JA, Dobrucki IT, Dobrucki LW, Borst LB, Lezmi S, Helferich WG, ... ... Fan TM, et al. Investigating the optimal size of anticancer nanomedicine. Proceedings of the National Academy of Sciences of the United States of America. 111: 15344-9. PMID 25316794 DOI: 10.1073/Pnas.1411499111 |
0.341 |
|
| 2014 |
Khanna C, Fan TM, Gorlick R, Helman LJ, Kleinerman ES, Adamson PC, Houghton PJ, Tap WD, Welch DR, Steeg PS, Merlino G, Sorensen PH, Meltzer P, Kirsch DG, Janeway KA, et al. Toward a drug development path that targets metastatic progression in osteosarcoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4200-9. PMID 24803583 DOI: 10.1158/1078-0432.Ccr-13-2574 |
0.355 |
|
| 2014 |
Portela RF, Fadl-Alla BA, Pondenis HC, Byrum ML, Garrett LD, Wycislo KL, Borst LB, Fan TM. Pro-tumorigenic effects of transforming growth factor beta 1 in canine osteosarcoma. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 28: 894-904. PMID 24684686 DOI: 10.1111/Jvim.12348 |
0.304 |
|
| 2014 |
Botham RC, Fan TM, Im I, Borst LB, Dirikolu L, Hergenrother PJ. Dual small-molecule targeting of procaspase-3 dramatically enhances zymogen activation and anticancer activity. Journal of the American Chemical Society. 136: 1312-9. PMID 24383395 DOI: 10.1021/Ja4124303 |
0.359 |
|
| 2014 |
Chakkath T, Lavergne S, Fan T, Bunick D, Dirikolu L. Preliminary Metabolism of Lomustine in Dogs and Comparative Cytotoxicity of Lomustine and Its Major Metabolites in Canine Cells Veterinary Sciences. 1: 159-173. DOI: 10.3390/Vetsci1030159 |
0.328 |
|
| 2013 |
Yang X, Belosay A, Du M, Fan TM, Turner RT, Iwaniec UT, Helferich WG. Estradiol increases ER-negative breast cancer metastasis in an experimental model. Clinical & Experimental Metastasis. 30: 711-21. PMID 24096710 DOI: 10.1007/S10585-012-9559-0 |
0.363 |
|
| 2013 |
Sternberg RA, Pondenis HC, Yang X, Mitchell MA, O'Brien RT, Garrett LD, Helferich WG, Hoffmann WE, Fan TM. Association between absolute tumor burden and serum bone-specific alkaline phosphatase in canine appendicular osteosarcoma. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 27: 955-63. PMID 23734720 DOI: 10.1111/Jvim.12121 |
0.332 |
|
| 2013 |
Goldsby RE, Fan TM, Villaluna D, Wagner LM, Isakoff MS, Meyer J, Randall RL, Lee S, Kim G, Bernstein M, Gorlick R, Krailo M, Marina N. Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group. European Journal of Cancer (Oxford, England : 1990). 49: 2384-91. PMID 23664013 DOI: 10.1016/J.Ejca.2013.03.018 |
0.317 |
|
| 2013 |
Holmes KE, Thompson V, Piskun CM, Kohnken RA, Huelsmeyer MK, Fan TM, Stein TJ. Canine osteosarcoma cell lines from patients with differing serum alkaline phosphatase concentrations display no behavioural differences in vitro. Veterinary and Comparative Oncology. PMID 23489774 DOI: 10.1111/Vco.12031 |
0.339 |
|
| 2013 |
Tang L, Gabrielson NP, Uckun FM, Fan TM, Cheng J. Size-dependent tumor penetration and in vivo efficacy of monodisperse drug-silica nanoconjugates. Molecular Pharmaceutics. 10: 883-92. PMID 23301497 DOI: 10.1021/Mp300684A |
0.329 |
|
| 2012 |
West DC, Qin Y, Peterson QP, Thomas DL, Palchaudhuri R, Morrison KC, Lucas PW, Palmer AE, Fan TM, Hergenrother PJ. Differential effects of procaspase-3 activating compounds in the induction of cancer cell death. Molecular Pharmaceutics. 9: 1425-34. PMID 22486564 DOI: 10.1021/Mp200673N |
0.582 |
|
| 2012 |
Wypij JM, Fan TM, Pondenis H. Expression of tumor endothelial markers (TEMs) in vitro in a canine hemangiosarcoma model of malignant angiogenesis. Journal of Clinical Oncology. 30: e21145-e21145. DOI: 10.1200/Jco.2012.30.15_Suppl.E21145 |
0.355 |
|
| 2011 |
Lucas PW, Schmit JM, Peterson QP, West DC, Hsu DC, Novotny CJ, Dirikolu L, Churchwell MI, Doerge DR, Garrett LD, Hergenrother PJ, Fan TM. Pharmacokinetics and derivation of an anticancer dosing regimen for PAC-1, a preferential small molecule activator of procaspase-3, in healthy dogs. Investigational New Drugs. 29: 901-11. PMID 20499133 DOI: 10.1007/S10637-010-9445-Z |
0.354 |
|
| 2011 |
Zinnen* S, Thamm D, Vail D, Fan T, Karpeisky A. Evaluation of a novel bone targeted aracytidine therapy in dogs with spontaneous osteosarcoma Bone. 48: S51. DOI: 10.1016/J.Bone.2010.10.145 |
0.317 |
|
| 2010 |
Hillman LA, Garrett LD, de Lorimier LP, Charney SC, Borst LB, Fan TM. Biological behavior of oral and perioral mast cell tumors in dogs: 44 cases (1996-2006). Journal of the American Veterinary Medical Association. 237: 936-42. PMID 20946081 DOI: 10.2460/Javma.237.8.936 |
0.337 |
|
| 2010 |
Peterson QP, Hsu DC, Novotny CJ, West DC, Kim D, Schmit JM, Dirikolu L, Hergenrother PJ, Fan TM. Discovery and canine preclinical assessment of a nontoxic procaspase-3-activating compound. Cancer Research. 70: 7232-41. PMID 20823163 DOI: 10.1158/0008-5472.Can-10-0766 |
0.358 |
|
| 2010 |
Fan TM. Animal models of osteosarcoma. Expert Review of Anticancer Therapy. 10: 1327-38. PMID 20735317 DOI: 10.1586/Era.10.107 |
0.352 |
|
| 2010 |
Paoloni MC, Mazcko C, Fox E, Fan T, Lana S, Kisseberth W, Vail DM, Nuckolls K, Osborne T, Yalkowsy S, Gustafson D, Yu Y, Cao L, Khanna C. Rapamycin pharmacokinetic and pharmacodynamic relationships in osteosarcoma: a comparative oncology study in dogs. Plos One. 5: e11013. PMID 20543980 DOI: 10.1371/Journal.Pone.0011013 |
0.309 |
|
| 2009 |
Fan TM. Intravenous aminobisphosphonates for managing complications of malignant osteolysis in companion animals. Topics in Companion Animal Medicine. 24: 151-6. PMID 19732734 DOI: 10.1053/J.Tcam.2009.02.003 |
0.357 |
|
| 2009 |
Fan TM, Charney SC, de Lorimier LP, Garrett LD, Griffon DJ, Gordon-Evans WJ, Wypij JM. Double-blind placebo-controlled trial of adjuvant pamidronate with palliative radiotherapy and intravenous doxorubicin for canine appendicular osteosarcoma bone pain. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 23: 152-60. PMID 19175734 DOI: 10.1111/J.1939-1676.2008.0221.X |
0.303 |
|
| 2008 |
Lucas PW, Fan TM, Garrett LD, Griffon DJ, Wypij JM. A comparison of five different bone resorption markers in osteosarcoma-bearing dogs, normal dogs, and dogs with orthopedic diseases. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 22: 1008-13. PMID 18564220 DOI: 10.1111/J.1939-1676.2008.0134.X |
0.315 |
|
| 2008 |
Fan TM, Barger AM, Fredrickson RL, Fitzsimmons D, Garrett LD. Investigating CXCR4 expression in canine appendicular osteosarcoma. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 22: 602-8. PMID 18466248 DOI: 10.1111/J.1939-1676.2008.0089.X |
0.336 |
|
| 2008 |
Fan TM, de Lorimier LP, Garrett LD, Lacoste HI. The bone biologic effects of zoledronate in healthy dogs and dogs with malignant osteolysis. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 22: 380-7. PMID 18346146 DOI: 10.1111/J.1939-1676.2008.0046.X |
0.332 |
|
| 2008 |
Fan TM, Kranz DM, Flavell RA, Roy EJ. Costimulatory strength influences the differential effects of transforming growth factor beta1 for the generation of CD8+ regulatory T cells. Molecular Immunology. 45: 2937-50. PMID 18321576 DOI: 10.1016/J.Molimm.2008.01.019 |
0.584 |
|
| 2008 |
Wypij JM, Fan TM, Fredrickson RL, Barger AM, de Lorimier LP, Charney SC. In vivo and in vitro efficacy of zoledronate for treating oral squamous cell carcinoma in cats. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 22: 158-63. PMID 18289304 DOI: 10.1111/J.1939-1676.2007.0010.X |
0.379 |
|
| 2007 |
Fan TM. Murine and canine models of appendicular osteosarcoma. Current Protocols in Pharmacology / Editorial Board, S.J. Enna (Editor-in-Chief) ... [Et Al.]. Unit 14.1. PMID 21948160 DOI: 10.1002/0471141755.Ph1401S37 |
0.354 |
|
| 2007 |
Fan TM. The role of bisphosphonates in the management of patients that have cancer. The Veterinary Clinics of North America. Small Animal Practice. 37: 1091-110; vi. PMID 17950884 DOI: 10.1016/J.Cvsm.2007.08.002 |
0.373 |
|
| 2007 |
Heller DA, Fan TM, de Lorimier LP, Charney SC, Barger AM, Tannehill-Gregg SH, Rosol TJ, Wallig MA. In vitro cyclooxygenase-2 protein expression and enzymatic activity in neoplastic cells. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 21: 1048-55. PMID 17939563 DOI: 10.1892/0891-6640(2007)21[1048:Ivcpea]2.0.Co;2 |
0.362 |
|
| 2007 |
Fan TM, Kranz DM, Roy EJ. Enhancing antitumor immunity: combining IL-12 with TGFbeta1 antagonism. Journal of Immunotherapy (Hagerstown, Md. : 1997). 30: 479-89. PMID 17589288 DOI: 10.1097/Cji.0B013E318031A2B2 |
0.574 |
|
| 2007 |
Fan TM, de Lorimier LP, O'Dell-Anderson K, Lacoste HI, Charney SC. Single-agent pamidronate for palliative therapy of canine appendicular osteosarcoma bone pain. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 21: 431-9. PMID 17552447 DOI: 10.1892/0891-6640(2007)21[431:Spfpto]2.0.Co;2 |
0.312 |
|
| 2007 |
Barger AM, Fan TM, de Lorimier LP, Sprandel IT, O'Dell-Anderson K. Expression of receptor activator of nuclear factor kappa-B ligand (RANKL) in neoplasms of dogs and cats. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 21: 133-40. PMID 17338161 DOI: 10.1892/0891-6640(2007)21[133:Eoraon]2.0.Co;2 |
0.325 |
|
| 2006 |
Lacoste H, Fan TM, de Lorimier LP, Charney SC. Urine N-telopeptide excretion in dogs with appendicular osteosarcoma. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 20: 335-41. PMID 16594591 DOI: 10.1111/J.1939-1676.2006.Tb02865.X |
0.337 |
|
| 2005 |
de Lorimier LP, Fan TM. Bone metabolic effects of single-dose zoledronate in healthy dogs. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 19: 924-7. PMID 16355693 DOI: 10.1111/J.1939-1676.2005.Tb02790.X |
0.314 |
|
| 2005 |
Barger A, Graca R, Bailey K, Messick J, De Lorimier LP, Fan T, Hoffmann W. Use of alkaline phosphatase staining to differentiate canine osteosarcoma from other vimentin-positive tumors Veterinary Pathology. 42: 161-165. PMID 15753469 DOI: 10.1354/Vp.42-2-161 |
0.366 |
|
| 2005 |
Fan TM, de Lorimier LP, Charney SC, Hintermeister JG. Evaluation of intravenous pamidronate administration in 33 cancer-bearing dogs with primary or secondary bone involvement. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 19: 74-80. PMID 15715051 DOI: 10.1892/0891-6640(2005)19<74:Eoipai>2.0.Co;2 |
0.379 |
|
| 2004 |
Milner RJ, Farese J, Henry CJ, Selting K, Fan TM, de Lorimier LP. Bisphosphonates and cancer. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 18: 597-604. PMID 15515572 DOI: 10.1111/J.1939-1676.2004.Tb02593.X |
0.369 |
|
| 2004 |
Souza CHM, Valli VEO, Fan TM, Vail DM. Detection of retinoid receptor expression patterns in canine normal lymph nodes and in nodal lymphomas Veterinary and Comparative Oncology. 2: 106-107. DOI: 10.1111/J.1476-5810.2004.0045M.X |
0.302 |
|
| 2004 |
Lacoste HI, Fan TM, de Lorimier LP, Charney SC. Differentiating effect of pamidronate on canine osteo-sarcoma cell lines in vitro Veterinary and Comparative Oncology. 2: 105-105. DOI: 10.1111/J.1476-5810.2004.0045K.X |
0.356 |
|
| 2004 |
Heller DA, Fan TM, Charney SC, de Lorimier LP, Wallig MA. The effects of cyclooxygenase-2 inhibition on apoptosis and cell cycle distribution using two in vitro models of nasal squamous cell carcinoma Veterinary and Comparative Oncology. 2: 102-102. DOI: 10.1111/J.1476-5810.2004.0045F.X |
0.326 |
|
| 2004 |
Lorimier LP, Fan TM, Charney SC, Lacoste HI, Heller DA, Endicott MM, Souza CH. Monitoring response to aminobisphosphonate therapy in canine osteosarcoma using dual energy x-ray absorptiometry (dexa) Veterinary and Comparative Oncology. 2: 101-102. DOI: 10.1111/J.1476-5810.2004.0045E.X |
0.346 |
|
| 2004 |
Fan TM, Charney SC, de Lorimier LP. Investigating the molecular mechanism of pamidronate-induced in vitro cytotoxicity in canine osteosarcoma cells Veterinary and Comparative Oncology. 2: 100-101. DOI: 10.1111/J.1476-5810.2004.0045D.X |
0.381 |
|
| 2004 |
Charney SC, Fan TM, de Lorimier LP, Lacoste HI. Investigating the in vitro interactive effects of ionizing radiation and pamidronate in a canine osteosarcoma cell line Veterinary and Comparative Oncology. 2: 99-100. DOI: 10.1111/J.1476-5810.2004.0045C.X |
0.318 |
|
| 2003 |
Fan TM. Lymphoma updates. The Veterinary Clinics of North America. Small Animal Practice. 33: 455-71. PMID 12852231 DOI: 10.1016/S0195-5616(03)00005-6 |
0.317 |
|
| Show low-probability matches. |